July 8, 2023 — It’s coming. Sometime before September we will be hearing about the results of the SELECT outcomes study of semaglutide in people with obesity and we may as well start getting ready to argue about it now. Because value is in the eye of the beholder. And this study is all about the long-term health value […]
June 30, 2023 — At the ASMBS Annual Meeting this week, a new study of major bad outcomes in people with both obesity and sleep apnea reminds us why metabolic surgery remains an important option for comprehensive obesity care. The risk of death, heart attacks, strokes, and other major bad cardiovascular outcomes is 37 percent lower if a person […]
November 17, 2022 — Can bariatric surgery cut the risk of a heart attack in half? The answer, of course, depends upon the population of patients and their risk profile. And we must remember that risk is a tricky thing to measure. But a recent study in JAMA Network Open found half the risk of a wide range of […]
November 12, 2021 — NASH (non-alcoholic steatohepatitis) is one of the most serious complications of untreated obesity. It’s very hard to treat. It can lead to liver failure, liver cancer, and death. So when a careful study of bariatric surgery shows an an 88 percent reduction in the risk of NASH progressing, this is big news. JAMA published this […]
August 4, 2021 — Bariatric surgery provides a benefit for reducing risks to heart health. This has been pretty clear for years now. Still, utilization remains low because the procedure seems daunting to many who need it. But a recent study suggests that an anti-obesity medicine – orlistat – might also reduce risks to heart health. In the European […]
